Intended for healthcare professionals

Letters Molnupiravir’s premature authorisation

Molnupiravir’s authorisation should be re-evaluated after the Panoramic trial is reported

BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o973 (Published 26 April 2022) Cite this as: BMJ 2022;377:o973

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: April 2022 to February 2024

Rendering graph...
AbstractFullPdf
Apr 20229139785
May 202243426150
Jun 2022390339
Jul 2022292042
Aug 2022139520
Sep 2022129028
Oct 202211547142
Nov 2022043937
Dec 2022043043
Jan 2023012220
Feb 202327016
Mar 202308712
Apr 202318228
May 20234761
Jun 202346124
Jul 20233663
Aug 20233624
Sep 20233930
Oct 20235372
Nov 20234351
Dec 202358104
Jan 20245242
Feb 20245324
Total50410105667